Glaze Life Sciences

Copenhagen, Denmark

Glaze Life Sciences is developing a non invasive device to monitor the blood glucose level.

$540K raised

Feb 2024

Convertible Note

Health Care Medical Device

Top Investors

BioInnovation Institute

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Glaze Life Sciences

How much funding has Glaze Life Sciences raised?

Glaze Life Sciences has raised $540K in total funding. The most recent round was Convertible Note. The last funding was announced in February 2024.

Who are Glaze Life Sciences's investors?

Glaze Life Sciences's investors include BioInnovation Institute.

Where is Glaze Life Sciences headquartered?

Glaze Life Sciences is headquartered in Copenhagen, Denmark.

What does Glaze Life Sciences do?

Glaze Life Sciences is developing a non invasive device to monitor the blood glucose level.

What stage is Glaze Life Sciences at?

Glaze Life Sciences is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 29, 2024.

MLA

"Glaze Life Sciences — Funding & Investors." VCBacked, February 29, 2024, https://www.vcbacked.co/company/glaze-life-sciences. Accessed July 2, 2026.

APA

VCBacked. (2024). Glaze Life Sciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/glaze-life-sciences

Wikipedia (cite web)

{{cite web |title=Glaze Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/glaze-life-sciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 29, 2024.

Similar Companies in Health Care

Allterum Therapeutics